[{"id":"22ada351-a09a-47fd-823b-9e72ade6fd98","acronym":"","url":"https://clinicaltrials.gov/study/NCT04609215","created_at":"2021-01-19T20:32:05.021Z","updated_at":"2024-07-02T16:36:11.787Z","phase":"Phase 1/2","brief_title":"ImmunoBreast - A Phase Ib Study","source_id_and_acronym":"NCT04609215","lead_sponsor":"Henrik Ditzel","biomarkers":" HER-2 • ER","pipe":" | ","alterations":" HER-2 positive • HR positive • ER expression","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HR positive • ER expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • gemcitabine • Alecsat (cytotoxic lymphocyte-based cancer vaccine)"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 04/21/2020","start_date":" 04/21/2020","primary_txt":" Primary completion: 05/21/2023","primary_completion_date":" 05/21/2023","study_txt":" Completion: 05/21/2023","study_completion_date":" 05/21/2023","last_update_posted":"2022-04-20"}]